Dutch Firms Not Updating Product Info Fast Enough Following Safety Alerts
Executive Summary
OTC marketing authorization holders in the Netherlands must respond more quickly to safety alerts issued at EU level which require product information updates, says regulator MEB.
You may also be interested in...
Dutch Self-Care Efforts Stumble As Supplement Prescription Costs Rise
Costs of prescriptions for vitamin D supplements in the Netherlands are spiraling with government moves to encourage self-care appearing to have had the opposite effect, according to new research.
Serious Skin Reactions Reported With Ibuprofen Use In Europe
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) advises ibuprofen manufacturers to add warnings of acute generalised exanthematous pustulosis associated with use of the drug to patient information leaflets.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.